Skip to main content
. Author manuscript; available in PMC: 2016 Apr 1.
Published in final edited form as: Clin Pharmacol Ther. 2015 Mar 15;97(4):419–427. doi: 10.1002/cpt.66

Figure 3.

Figure 3

Association of the NASH severity score (NAS+Fibrosis severity scores) with morphine glucuronide Cmax (A) and AUC0-last (B). Values for patients with NASH (triangles) and for healthy subjects (circles) are shown with the linear regression and its 95% confidence limits (shaded area). The NASH severity score is the sum of the NAS and fibrosis biopsy scores; for healthy subjects, an imputed value of zero was assumed.